J.P. Morgan Day 3: First TCR Therapy On The Horizon, Asian Firms Make Their Mark

13 Jan 2022

• By Scrip Team

Daily notebook from the virtual J.P. Morgan Healthcare Conference: new immunotherapies coming, what the year could look like in deals and new updates from multiple Asian companies.

J.P. Morgan Daily Notebook 2022 Day 3 — • Source: Alamy

J.P. Morgan Day 3: First TCR Therapy On The Horizon, Asian Firms Make Their Mark

More from Archive

More from Pink Sheet